您的位置: 专家智库 > >

国家重点基础研究发展计划(2011CB911000)

作品数:9 被引量:25H指数:2
相关作者:甄珍唐丽娟蒋健晖王铮马洁更多>>
相关机构:湖南大学深圳市宝安区疾病预防控制中心中国医学科学院北京协和医学院更多>>
发文基金:国家重点基础研究发展计划国家自然科学基金中国博士后科学基金更多>>
相关领域:理学医药卫生一般工业技术生物学更多>>

文献类型

  • 9篇期刊文章
  • 1篇会议论文

领域

  • 6篇理学
  • 2篇医药卫生
  • 2篇一般工业技术
  • 1篇生物学
  • 1篇自动化与计算...

主题

  • 2篇纳米
  • 2篇BIOSEN...
  • 2篇FLUORE...
  • 2篇THIOLS
  • 1篇蛋白
  • 1篇多柔比星
  • 1篇移植瘤
  • 1篇乙酰
  • 1篇乙酰化
  • 1篇荧光
  • 1篇荧光猝灭
  • 1篇散射
  • 1篇适体
  • 1篇索拉非尼
  • 1篇探针
  • 1篇肿瘤
  • 1篇肿瘤药
  • 1篇组蛋白
  • 1篇组蛋白乙酰化
  • 1篇猝灭

机构

  • 2篇湖南大学
  • 1篇河南城建学院
  • 1篇中国医学科学...
  • 1篇中国医学科学...
  • 1篇深圳市宝安区...

作者

  • 1篇俞汝勤
  • 1篇唐平章
  • 1篇安常明
  • 1篇李正江
  • 1篇沈国励
  • 1篇韩志楷
  • 1篇龙昊旭
  • 1篇马洁
  • 1篇吴会旺
  • 1篇欧阳湘元
  • 1篇王铮
  • 1篇蒋健晖
  • 1篇唐丽娟
  • 1篇甄珍
  • 1篇刘雪平

传媒

  • 3篇Scienc...
  • 2篇Chines...
  • 1篇高等学校化学...
  • 1篇化学学报
  • 1篇Scienc...
  • 1篇中华耳鼻咽喉...

年份

  • 1篇2016
  • 1篇2014
  • 3篇2013
  • 2篇2012
  • 3篇2011
9 条 记 录,以下是 1-10
排序方式:
Colorimetric and fluorescent detection of biological thiols in aqueous solution被引量:2
2013年
Received 10 December 2012 Received in revised form 5 January 2013 Accepted 10 January 2013 Available online 8 February 2013
Yin-Hui LiJin-Feng YangChang-Hui LiuJi-Shan LiRong-Hua Yang
Terminal protection of small molecule-linked ssDNA-SWNT nanoassembly for sensitive detection of small molecule and protein interaction被引量:2
2013年
Received 3 December 2012 Received in revised form 27 December 2012 Accepted 31 December 2012 Available online 4 February 2013
Yu WangDian-Ming ZhouZhan WuLi-Juan TangJian-Hui Jiang
组蛋白乙酰化的耦合增强拉曼散射生物传感方法被引量:2
2013年
提出了一种组蛋白乙酰化修饰检测的耦合增强拉曼散射生物传感新方法.该方法以金纳米粒子为表面增强拉曼散射(SERS)基底,表面修饰乙酰化组蛋白H3多肽为识别探针,对甲氧基苯硫酚(4-MTP)为拉曼标记物,制备了组蛋白乙酰化修饰检测的SERS纳米探针.通过紫外可见吸收光谱与动态光散射分析,证实了组蛋白乙酰化抗体可介导SERS纳米粒子发生可控组装与聚集,使SERS纳米探针间发生局域电场共振耦合,产生显著增强的SERS信号.基于此,通过待测抗原与SERS纳米探针对抗体的竞争性相互作用,我们设计了组蛋白乙酰化修饰检测的竞争免疫SERS生物传感方法.该法操作简便、快速、重现性好,且裸眼即能进行可视化鉴定.通过设计不同染料标记的SERS纳米探针,该法有望实现多种组蛋白修饰的复合检测.
龙昊旭甄珍唐丽娟蒋健晖
关键词:乙酰化表面增强拉曼散射纳米探针免疫分析
Cell-SELEX-based aptamer-conjugated nanomaterials for enhanced targeting of cancer cells被引量:13
2011年
Early detection and treatment of cancer depends on developing highly sensitive and specific methods for targeting cancer cells. To do this, aptamers, which are generated by a novel technique caUed ceU-SELEX (systematic evolution of ligands by exponential enrichment), have been widely applied in cancer cell targeting based on such merits as high target affinity and specificity, small size, minimal immunogenicity, and ease of chemical modification. Furthermore, aptamers can gain more flexibility as cancer cell targeting tools when conjugated to nanomaterials, including metallic nanoparticles, quantum dots, silica nanoparticles, and carbon nanomaterials, among others. In this review, we discuss the use of cell-SELEX-based aptamer-nanomaterials conjugates as novel molecular tools for enhanced targeting of cancer cells.
KONG RongMei, CHEN Zhuo, YE Mao, ZHANG XiaoBing & TAN WeiHong State Key Laboratory for Chemo/Biosensing and Chemometrics
关键词:APTAMERNANOMATERIALTARGETING
Carbon Nanotubes as Effective Quenchers for Designing of Fluorescent Biosensing Platform
<正>Over the past few years,carbon nanostructures,such as single-walled carbon nanotubes(SWNTs)and graphenes,ha...
Ronghua YangWeihong Tan
文献传递
Design of multiplex logic gates:combining regulation of DNA structure with logical calculation
2014年
In this paper,we proposed a facile and accurate way for controlling multiplex fluorescent logic gates through changing the exciting and the observing wavelengths.As proof-of-principle,a Pb2+-specific DNAzyme probe and a thymine(T)-rich DNA probe were introduced to a double-stranded(ds-)DNA.The addition style of the two ions served as the four inputs by changing the distance of the three fluorophores,6-carboxyfluorescein(FAM),ALEXA 532(ALEXA)and carboxytetramethylrhodamine(TAMRA),all of which were modified on the dsDNA probe.Compared with the previous methods,the present approach needed neither different inputs nor the change of sequence of the probe to achieve multiplex logic gates.Furthermore,the modularity of the strategy may allow it to be extended to other types of logic gates.
TAO JiaZHENG JingLI JiShanZHAO PengLI JuanPingMA ChengYI MeiYANG RongHua
关键词:FRETDNA
基于目标物诱导置换及纳米金催化的新型荧光技术检测腺苷被引量:1
2012年
在一定条件下,磁性纳米颗粒上修饰的腺苷核酸适体与纳米金标记的核酸探针杂交;再加入目标物腺苷诱导适体构象变换,并置换出金标探针;经磁场分离后,游离的金标探针进一步用于催化抗坏血酸还原铜离子,使铜离子对钙黄绿素的荧光猝灭得到抑制.由于极少量的纳米金能够催化大量铜离子还原并沉积在其表面,铜离子浓度急剧降低,从而改变钙黄绿素的荧光信号.实验结果表明,腺苷的动力学响应浓度范围为100 pmol/L~10 nmol/L,检出限低至80 pmol/L.核酸适体的高度特异识别性能保证了该方法具有良好的选择性.
刘雪平欧阳湘元吴会旺沈国励俞汝勤
关键词:纳米金磁性纳米颗粒核酸适体
索拉非尼联合脂质体阿霉素治疗甲状腺低分化癌裸鼠移植瘤的疗效观察被引量:2
2012年
目的评估索拉非尼、脂质体阿霉素及两者联合应用治疗甲状腺低分化癌裸鼠移植瘤的疗效。方法用脂质体阿霉素和索拉非尼治疗甲状腺低分化癌裸鼠皮下移植瘤模型,裸鼠按随机数字法分为7组,为空白对照组、溶剂对照组、单药脂质体阿霉素组、索拉非尼组、低剂量联合组、中剂量联合组和高剂量联合组,观察肿瘤生长情况,评估两种药物的疗效。结果利用索拉非尼和脂质体阿霉素对甲状腺低分化癌模型进行化疗,空白对照组、溶剂对照组、单药脂质体阿霉素组、索拉非尼组、低剂量联合组、中剂量联合组、高剂量联合组化疗结束后的最终肿瘤体积分别为(1274.13±393.76)mm3、(1060.00±469.05)mm3、(726.76±488.22)mm3、(451.54±97.75)mm3、(518.37±164.44)mm3、(310.51±210.53)mm3和(228.44±129.21)mm3,各组移植瘤最终瘤体质量分别为(1.13±0.42)g、(0.91±0.39)g、(0.78±0.45)g、(0.55±0.17)g、(0.52±0.19)g、(0.34±0.21)g和(0.194-0.09)g,单药脂质体阿霉素组、索拉非尼组、低剂量联合组、中剂量联合组、高剂量联合组的抑瘤率分别为30.8%、40.8%、42.3%、62.9%和72.6%,高剂量联合组抑瘤率除与中剂量联合组差异无统计学意义外(P=0.357)均高于其余各组,中剂量联合组优于单药脂质体阿霉素组(P;0.001),而与索拉非尼组差异无统计学意义(P=0.192)。各治疗组平均瘤体质量均明显低于空白对照组(F=9.985,P〈0.05)。各治疗组均无荷瘤鼠死亡,高剂量联合组荷瘤鼠体质量在治疗过程中较其余各治疗组有明显减轻(F=14.792,P〈0.05)。结论脂质体阿霉素和索拉非尼无论是单药还是联合应用对甲状腺低分化癌移植瘤模型均有明显的抑瘤作用,中剂量联合疗效明显且副作用小。
安常明王铮韩志楷李正江唐平章马洁
关键词:肿瘤多柔比星
Recent advances in the development of nanomaterials for DC-based immunotherapy被引量:3
2016年
As professional antigen presenting cells, dendritic cells(DCs) greatly determine the quality of the innate and adaptive immunities. Therefore, DC-based immunotherapy has been one of the hotspots in cancer immunotherapy in recent years. Although this unique therapeutic strategy has been approved by U.S. Food and Drug Administration for prostate cancer treatment, the efficacy of DC-based immunotherapy remains to be further improved. Moreover, it is still not completely clear about the immunological basis of DCs, which is another hurdle for the progress of DC-based immunotherapy. Due to their unique physicochemical properties, nanomaterials have shown potentials in addressing these above mentioned problems and have provided important guidelines for optimizing DC-based immunotherapy. However, it is still at the starting stage for this emerging field and there are many critical questions in the rational design of this therapeutic strategy to be answered. Therefore, it is greatly necessary to review and analyze recent progresses in this field. In this review, we mainly focus on the development of various types nanoparticles for DC-based immunotherapy. The existed challenges in this field are also discussed.
Ligeng XuJian XiangRui PengZhuang Liu
关键词:IMMUNOTHERAPYTRACKINGNANOMATERIALS
DNA template-synthesized silver nanoparticles:A new platform for high-performance fluorescent biosensing of biothiols
2011年
To develop the high-performance fluorescent bio-sensors, the metal nanoparticles were employed as nanoquenchers and at- tracted reasonable attention in the design of fluorescent biosensors. In this work, silver nanoparticles (AgNPs) were obtained via reduction of Ag+ on FAM-labeled DNA template. For the tight binding between AgNPs and DNA, the tem- plate-synthesized AgNPs turned out high quenching efficiency and could be applied as super nanoquenchers to establish the biosensing platform for fluorescent detection. As an example, the template-synthesized DNA-AgNPs conjugates were em- ployed in sensing thiols. By forming S-Ag bonds, thiols interact intensely with AgNPs and replace the FAM-labeled DNA off from the surface of AgNPs, resulting in a fluorescence enhancement. Besides the advantages of lower background and higher signal-to-background ratio (S/B), the conjugates present better stability, making them applicable in complicated biological fluids. To further evidence the feasibility of sensing thiols in real samples, the thiols in human urine were detected. The total amount of free thiols found in human urine was ranging from 229 μM to 302μM with the proposed sensor. To conclude the reliability, low content of Cys was added and the recovery was 98%-103%.
JIN JianYuOUYANG XiangYuanLI JiShanJIANG JianHuiWANG HaoWANG YongXiangYANG RongHua
关键词:THIOLS
共1页<1>
聚类工具0